Aromatase inhibitor high-throughput screening model based on fluorescence detection principle
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- CHINA PHARM UNIV
- Publication Date
- 2013-06-12
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of pharmacology. A high-throughput screening model of aromatase inhibitors in vitro is constructed by using a homogeneous time-resolved fluorescence detection technology, which is used for high-throughput detection of aromatase inhibitory activity of test samples. Background technique
[0002] Steroid A-ring aromatase mainly exists in ovary and placenta, but also in other tissues, such as brain, adrenal gland, testis, bone marrow, fat, skin, muscle and some tumor tissues. Aromatase takes androgen as a substrate, and with the participation of oxygen and NADPH, undergoes two hydroxylations at the 19-position of the substrate, and finally aromatizes the A ring to generate estrogen products. Inhibition or inactivation of aromatase activity can lead to a decrease in estrogen levels in the body, thereby interfering with estrogen-related physiological processes such as ovulation, implantation, etc., and can also cause estrog...